James W Murrough, MD, PhD
Icahn School of Medicine · Icahn School of Medicine at Mount Sinai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James W Murrough, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:07 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07908563 · Dupilumab in Major Depressive DisorderIcahn School of Medicine at Mount Sinai · recruiting · Major Depressive Disorder · principal investigator
- Ph2NCT04979910 · Targeting IL-17A for Treatment-Resistant DepressionIcahn School of Medicine at Mount Sinai · completed · Major Depressive Disorder · principal investigator
- Ph2NCT04827901 · XEN1101 for Major Depressive DisorderJames Murrough · completed · Major Depressive Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Developing Neuronal KCNQ Channel Modulators for Mood DisordersR33MH111932 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI James Warren Murrough · fiscal years 2021 to 2023Named on NCT04827901
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.